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In 1964, Selikoff et al. (1) found a three-
fold excess risk of cancer of the stomach,
colon, and rectum among insulation work-
ers exposed for 20 or more years. Since that
time there has been a number of other
studies ofasbestos workers and reviews on
the relationship of asbestos exposure and
gastrointestinal (GI) cancer. The hypothe-
sis ofan increased risk ofGI cancer among
asbestos workers originated from the 1964
study of 632 asbestos insulation workers.
The notion has persisted, although results
of subsequent studies are not consistent.
Reviewers of the asbestos-GI cancer
hypothesis have reached a variety of con-
clusions, such as:
*"Exposure to asbestos is associated
with the subsequent development of gas-
tro-intestinal malignancies. In the absence
of an explanation to the contrary, this
exposure must be regarded as causal," and
only those causes identified after 20 or
more years latency should be accepted. (2:
23)
*"No simplistic cause-effect relation-
ship can be ascribed to asbestos at the pre-
sent time and the answer to the question,
'Does asbestos exposure cause gastrointesti-
nal cancer?' must await the results ofaddi-
tional studies." (3: 1189)
*"The simplest explanation of the
excess mortality of gastro-intestinal cancer
. . . and in our opinion the most likely, is
that it results largely or wholly from misdi-
agnosis ofcancer ofthe lung and mesothe-
lioma of the pleura or peritoneum. We
cannot, of course, rule out the possibility
that asbestos may cause a small number of
cancers in many different organs, even
though there is no strong evidence that it
does." (4: 90)
*"Asbestos exposure is the best defined
occupational risk factor for colorectal can-
cer." (5: 123)
*"No consistent evidence was found to
indicate that exposure to asbestos increases
the risk ofgastrointestinal cancer." (6:75)
*.... significant asbestos exposure, as
indicated by a lung cancer standardized
mortality-ratio (SMR) of at least 200, is
associated with an elevated gastro-intestinal
cancer SMR." (7: 79)
The various views expressed above
relate to gastrointestinal cancer, and there-
Table 1. Overweight as a riskfactorfor colon cancera
RR by level ofoverweight
Study design and reference Lowerweight Higherweight Comments
Cohort(10) 1.0 1.26 1.23 1.53* Incidence of colorectal cancer
in males significantwhen
>130% overweight
Cohort(11) 1.0 0.86 1.6 1.78 Increased incidence in
males when .60th percentile at
age.55
Case-control (12) Third tertile: 1.14 Males
Cohort(13)
Males 1.0 2.8* 2.4* Retired subjects; increased
incidence in uppertwo-thirds of
Females 1.0 0.95 1.19 distribution of Quetlet's index
Cohort(14) 1.04 per 0.1 unit in Quetlet index Incidence among males and
females; significant association
Cohort(15) No apparent association 14-yearfollow-up ofSwedish
twin registry; overweight at25,
40, or both 25and 40years of
age
Case-control (16) OR forhighest compared to Males and females
low category of body mass index = 2.0
Abbreviations: RR, risk ratio; OR, odds ratio.
8Overweightwas usually measured as body mass index.
*p<0.05.
What is the evidence that exposure to
asbestos causes colon cancer? This weight-
of-eviden. reviw considers epidemiologic
evidencefr cohort studi...of asbestos-
exposed: workers, case-control studies of
colon cancer, animal bioassays, and other
corroborative evidence. The major evidence
for acausal asociation ath exposure is a
combined colorectal dized mortality
ratio (SMR) of 1.5 for asbestos cohorts
where the lung cancer SMR was greater
than twofold. However, uiidiagnosis may
spuriously elevte the SMR. The strongest
evidence against a causal association
between colon cancer and asbestos exposure
is the lack ofaneposure-response radient
in asbestos cohorts where trends for lung
cancer ae. observed. Population-based
case-controlstudi'es ofcoloncancer do not
show any consistent risk associated with
asbestos exposure. Long-term ingestion
studies show no evidence of an increased
incidence ofcolon cancer in animals bythis
route Ofexposure and do not provide bio-
logica plusibility for a causal association
bewen sbetexposure adScoon cancer.
Ki4yu'o,&:asbestos, colon ancer, colorecal
cancer, grointestinal cancer, weight-of-
evidence review. Environ Health Perspect
102:1038-1050 (1994)
fore, include such sites as the esophagus,
stomach, small intestine, colon, rectum,
and pancreas. This review will narrow the
question to colorectal cancer, and where
possible, to colon cancer. Before arriving at
a conclusion, the following issues need to
be considered: What are some of the
known risk factors for colon cancer? Can
they bias the results ofepidemiologic stud-
ies? Is misdiagnosis likely to bias the esti-
mates of risk in asbestos-exposed popula-
tion? What is the experimental evidence
from animal studies regarding the risk of
colon cancer from ingested asbestos?
The epidemiologic data are reviewed
for strength of association, temporality (is
there sufficient latency after first expo-
sure?), exposure response, and consistency.
Results from studies of asbestos workers
(or workers exposed to asbestos such as
maintenance workers) are summarized
when colon or colorectal cancer (CRC)
risks are provided. Exposure-response data
are also evaluated. The determination of
whether asbestos causes colon cancer
depends in part on these factors. Given
there is no bias orconfounding, strong evi-
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Table 2. Physical activity as a riskfactorfor colon cancer
RR by level of activity
Study design and reference High Low Comments
Proportional incidence (17) 1.0 1.3 1.6 Proportional incidence ratios;
rated byjob
Case-control (18) 1.0 1.53* 1.58* 2.10* Proportion ofwork-years in
sedentaryjob
Cohort (19) 1.0 1.3 Physically active job vs. seden-
taryjob attime of Swedish cen-
sus, 19-year follow-up
Cohort ( 13)
Males 1.0 1.12 2.5 Time/day spent in physical
Females 1.0 1.39 1.12 activity in retirement
Twin registry cohort (15) 1.0 3.6*total Similar risk of 1.6 for males
1.0 1.6 and females for recreational
and occupational activity
Case-control (16)
Males 1.0 0.84 1.14 1.43 Total activity; when com-
Females 1.0 1.03 1.10 2.08 pared to intense activity,
RR for low activity is 3.4 (2.1)
for males (females)
Case-control (20)
Males 1.0 1.0 1.22* Protective effect in de-
Females 1.0 1.05 1.47* scending and sigmoid colon
but not in appendix, cecum,
and ascending colon
Cohort (21)
Total 1.0 1.79* 1.41* Physical activity indexfrom
Home 1.0 1.5* (mostly sitting) questionnaire; Japanese
Work 1.0 1.39* (mostly sitting) males in Hawaii
Case-control (22) 1.0 1.1 1.4* Males; occupational physical
activity
Case-control (23) 1.0 2.0* 2.0* Males; occupational activity;
recreational activity less
importantthan activity at
work
RR, risk ratio.
*p<0.05.
Table 3. Alcohol consumption as a riskfactorfor colon cancer
RR by level of consumption
Study design and reference Low High Comments
Case-control (24)
Males 1.0 1.38 1.54* Ounces/year, controlling for
Females 1.0 1.19 1.44 smoking, age, and race;
among males, OR for highest
wine, beer, and hard liquor
exposure levels = 2.14*,
1.68*, 1.61*.
Cohort(25) 1.0 0.57 1.05 0.88 Japanese males in Hawaii;
ounces/month at beginning
of 14-yearfollow-up
Case-control (26)
Males 1.0 0.6 0.4 0.8 Total alcohol intake, higher
Female 1.0 1.4 1.2 2.0 riskforspirits
Cohort (13)
Male 1.0 2.24* 2.42* Colorectal cancer, but similar
Females 1.0 1.13 1.45 findings for colon; retirement
community
Cohort (14)
Males 1.0 0.89 1.15 1.16 OR for ex-drinkers = 0.81,
Females 1.0 1.29 1.80 2.56 males; 0.74, females
Case-control (27) No apparent association Stratified by coffee consump-
tion and ±4 drinks/day
Abbreviations: RR, risk ratio; OR, odds ratio.
*p<0.05
dence for a causal association includes a
consistent increased risk of colon cancer
occurring 15-20 years or more after first
exposure, with the risk increasing with
exposure.
Another criterion useful in evaluating
causality is plausibility. Are animals
exposed to asbestos at increased risk of
colon cancer? What are the mechanisms of
action for asbestos, and are they relevant to
the human colon? These are the criteria
that will be used to evaluate the weight-of-
evidence in determining whether asbestos
causes colon cancer (8,9).
Some Risk Factors for Colon Cancer
Overweight has been shown in a number
ofstudies to increase the risk ofcolon can-
cer. All but one of the studies reviewed
showed an increased risk when overweight.
The risk for someone 20-30% overweight
is estimated at about twofold (Table 1).
There is a consistent body of evidence
suggesting increased physical activity
decreases the risk ofcolon cancer. Such an
association is biologically plausible, as
physical activity stimulates peristalsis,
thereby reducing stool transit time and
contact time between carcinogens in the
fecal material and the lining of the colon
(21). The inverse association is observed
when activity is estimated by job title and
by more direct evaluation of activity. The
risk of low activity/sedentary jobs ranges
from about 1.4 to 3.7 (Table 2).
Overweight and increased physical
activity are not considered significant con-
founders in the studies reviewed, as the risk
is modest. Ifconfounding is occurring (say
if higher-exposed workers are more active
and have a lower proportion of over-
weight), the effect will be to decrease their
perceived risk. However, it is in those stud-
ies with exposure-response trends that
confounding is considered least likely.
The possible role of alcohol consump-
tion as a risk factor for colon cancer is not
obvious. At least one study has shown an
association among women but not among
men (14). Three studies show about a
1.6-2.2 increased risk for those drinking
daily (13,14,26). At least two studies sug-
gest no association (25,27). The reason for
the differences is not known (Table 3).
The 1964 Surgeon General's report on
Smoking and Health (28) reports observed
and expected deaths from seven prospec-
tive studies for cancer ofthe small intestine
and colon for cigarette smokers only. The
overall mortality ratio was 0.93 (95% CI,
0.84, 1.03). Three of the seven studies
were positive (SMRs ranging from 1.1 to
1.4), and four were negative (SMRs from
0.4 to 0.9). Perhaps because of the appar-
ent lack of excess mortality, there are rela-
tively few analytic studies investigating the
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Table 4. Cigarette smoking as a riskfactorfor colon cancer
Study design and reference
Case-control (24)
Males
Females
Never
1.0
1.0
0.65*
1.18
RR by level of smoking
Increasing pack-years
0.73
0.94
Comments
0.79
0.66
Pack-years smoked; con-
trolled for age and race; no
apparent association
Retired cohort(13)
Males
Females
Cohort(14)
Male and female
Case-control (16)
Males
Females
Case-control (27)
Case-control (20)
NS
1.0
1.0
Ever
0.60
1.20
Ever vs. never; unadjusted and calcu-
lated from number of cases
and controls
No association
NS
1.0
By smoking categoryfor all strata of
coffee consumption
Smoker + EXS
1.0
Males and females
Abbreviations: RR, risk ratio; NS, nonsmoker; EXS, ex-smoker.
*p<0.05.
Table 5. Comparison of standardized mortality ratios (SMRs) for colon and colorectal cancers in studies
of asbestos workers where causes of death are available
Observed/expected = SMR (95% Cl)
Lung cancer SMR Colon cancer Colorectal cancer Reference
> 20-year latency
1.36 5/15.4 = 0.33 (0.10, 0.68) 14/27.4 = 0.51 (0.27,0.82) (32)
1.71 7/13.4 = 0.52 (0.21, 1.08) 23/24.8 = 0.93 (0.58, 1.35) (33)
2.71 14/14.24 = 0.98 (0.53, 1.58) 23/19.9 = 1.16 (0.72, 1.69) (34)
Total 26/43.04 = 0.60 (0.39, 0.87) 60/2.1 = 0.83 (0.63, 1.06)
No latency
0.99 56/50.6 = 1.11 (0.94,1.44) 91/83.3 = 1.09(0.88,1.33) (35)
1.15 12/5.73 = 2.09 (1.08, 3.66) 16/9.44 = 1.69(0.95, 2.65) (36)
1.69 8/17.9 = 0.45(0.2, 0.89) 24/30.2 = 0.79 (0.50, 1.15) (33)
1.8 32/30.16 = 1.06 (0.73, 1.5) 67/57.93 = 1.16(0.89, 1.46) (37)
2.1 6/4.4 = 1.37 (0.48, 2.70) 10/7.6 = 1.32 (0.62, 2.28) (38)
Total 114/108.8 = 1.05 (0.86, 1.25) 208/188.5 = 1.10 (0.96, 1.26)
association of colon cancer and smoking.
Table 4 summarizes six more recent stud-
ies. None of these studies shows a statisti-
cally significant colon cancer risk associat-
ed with smoking; two ofthe six show a risk
ratio greater than one for smokers. These
results are not dissimilar from the 1964
report and suggest that ifthere is a risk of
colon cancer from smoking, it is small.
Neither alcohol nor smoking can be
significant confounders, as the association
with colon cancer is negligible.
Colorectal Cancer: Diagnosis and
Grouping
Doll and Peto (4) report that in asbestos
cohorts, 17-20% of the excess mortality
from lung cancer is attributed to GI and
other cancers. They argue that this excess
has one of two explanations. Either
asbestos exposure causes cancer in practi-
cally every organ, or some ofthe lung can-
cers and mesothelioma deaths are misclas-
sified as GI cancers. The latter is consid-
ered more likely.
Lung cancer may clinically mimic other
diseases, and its common occurrence was
not generally realized at least until the
1960s (1964 was the date of the Surgeon
General's report on smoking that raised
consciousness concerning the relationship
of smoking and lung cancer). Meso-
thelioma misclassification is even more
likely. Pleural mesothelioma was not recog-
nized as a specific cancer until 1960, and
peritoneal mesothelioma did not achieve
some recognition until 1964.
Misclassification of GI cancers during
this time period and before is supported by
Newhouse and Wagner (29). They com-
pared gastrointestinal cancer deaths deter-
mined from the death certificate with caus-
es of death (COD) determined by addi-
tional necropsy and histological material.
The number of GI tumors was reduced
from 14 to 7, lung cancer increased from
39 to 42 (8 added and 5 removed), and
mesotheliomas increased from 5 to 20.
Seven ofthe deaths reclassified as mesothe-
liomas were from gastrointestinal cancers,
3 from other tumors, and 5 from lung can-
cers.
Doll and Peto (4) suggest the data pre-
sented by Selikoff et al. (30) regarding mis-
classification cannot be interpreted because
the extent of"best evidence" is not known.
It seemed to Doll and Peto unlikely that
there were no transfers out of asbestos-
related cancers, while 37% of the transfers
into asbestos-related categories were not
thought to be asbestos related. Selikoff
later concluded that about one-half
(23/49) ofthe pancreatic cancers were mis-
classified. These are the data on which the
asbestos/GI cancer hypothesis is based.
Doll and Peto (4) considered classifica-
tion ofdeath from death certificates at pre-
sent to be somewhat better than previous-
ly. This seems to be supported by Percy et
al. (31). They compared causes ofdeath on
death certificates with hospital diagnoses.
Colon cancer had a high detection rate
(89%), but only 79% of the deaths were
confirmed by the hospital diagnosis. For
rectal cancers the rates were 56% and
86%. Thus, colon cancer was overreport-
ed, and rectal cancer was underreported.
Colorectal cancer had both high detection
and high confirmation rates (93 and 95%,
respectively). Detection and confirmation
rates for stomach and pancreatic cancers
showed good agreement (-90%) as did
lung cancer (-95%).
The effect of overreporting colon can-
cer is to spuriously inflate the number of
deaths ascribed to it. To bias the SMRs,
Environmental Health Perspectives
Never
1.0
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1.71
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1.03
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2.63*
0.71
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0.76
Current
1.8
1.35
>1 pack/day
1.35
1040the diagnoses would have to be increased
more among asbestos workers than nonas-
bestos workers, and the asbestos-related
respiratory cancers would have to be misdi-
agnosed as GI cancers. Misclassification
appeared to be a significant problem before
the 1980s in asbestos cohorts based on best
evidence. The problem should be greatest
where asbestos exposure is highest because
the proportion of asbestos-related cancers
will be higher than in less-exposed workers.
The effect of misclassification is to spuri-
ously reduce SMRs for respiratory cancers
and spuriously inflate SMRs for colon can-
cer, particularly in high-exposed workers.
The effect in low-exposed groups is not
considered significant.
Percy et al. (31) do not provide any
information as to the "correct" diagnosis
and whether it might be mesothelioma.
Whether a person exposed to asbestos is
more likely to be misdiagnosed for colon
cancer compared to a person not exposed
to asbestos is unknown, but "diagnostic
suspicion bias" does occur.
In the asbestos studies being reviewed,
there are eight cohorts reporting colon can-
cer and rectum cancer separately; three
cohorts stratify by >20 years latency, and
five cohorts do not consider latency. The
SMRs for colon and colorectal cancers are
similar where latency is not considered.
Where latency is considered, the SMR for
CRC is 0.83, whereas the SMR for colon
cancer in these same studies is 0.60, about
30% less (Table 5). That is, when latency
was considered, the SMR for CRC was
always greater than that for colon cancer
alone. Thus the SMR for CRC used in the
analysis of asbestos cohorts may overesti-
mate the true risk ratio for colon cancer.
An important reason for stratifying by
latency is that both CRC and lung cancer
are generally considered to take about 20
years or so to develop after exposure to an
etiologic agent. Thus a restriction to >20-
year latency should exclude at least some of
the nonoccupational cases.
Colorectal Cancer inAsbestos
Workers: Cohort Studies
The validity ofthe hypothesis that asbestos
causes colon cancer is tested here among
asbestos workers where a major portion of
the cohort is presumed to be exposed.
Because asbestos is a known lung carcino-
gen and lung cancer shows a linear rela-
tionship to asbestos exposure (39), the risk
of lung cancer provides a surrogate esti-
mate of asbestos exposure. In the analysis
presented below, the risk ofCRC is strati-
fied into cohorts with high asbestos expo-
sure (risk of lung cancer greater than
twofold) and cohorts with lower asbestos
exposure (risk of lung cancer less than
twofold).
The SMR for lung cancer in asbestos-
exposed workers is only a surrogate mea-
sure ofexposure because there is no control
for smoking, a major cause oflung cancer.
Smoking and asbestos exposure together
multiply the risk oflung cancer, but smok-
ing does not appear to increase the risk of
colon cancer. The SMR for lung cancer
includes the effect of exposure to both
asbestos and cigarette smoke. The lower
SMRs for lung cancer could in part be due
to less smoking and/or less asbestos expo-
sure. The justification for using lung can-
cer SMRs as a surrogate for asbestos expo-
sure is based on the demonstrated relation-
ship between asbestos exposure and lung
cancer. Two assumptions are made that
support the idea that increased lung cancer
SMRs indicate asbestos exposure more
than they indicate prevalence of smoking:
1) smoking prevalence is similar in the
asbestos cohorts, 2) smoking alone is
unlikely to increase the lung cancer SMRs
much above twofold, even with a high
incidence ofsmoking.
Results are combined within each cate-
gory by summing observed and expected
deaths for an overall observed/expected risk
ratio, thereby crudely evaluating risk of
CRC at low and high exposures using risk
of lung cancer as a surrogate of exposure.
Results are presented for cohorts in which
only workers with 10 or more years since
date of hire (and by implication date of
first exposure) are included.
Asbestos exposure has been specifically
identified with mesothelioma, so the pro-
portion ofmesotheliomas can also serve as
a surrogate measure of asbestos exposure.
Mesothelioma is affected more by type of
asbestos than by exposure, however, as a
clear exposure-response relationship has
not been demonstrated. With some excep-
tions, the classification ofasbestos exposure
by lung cancer SMRs and percent meso-
theliomas is consistent. The mean percent
mesotheliomas for cohorts with lung
SMRs <2 is 0.8%, compared to 4.9% for
studies where lung cancer SMRs are >2.
Six of the ten studies with lung cancer
SMRs <2 have <1% mesotheliomas, five of
six of the studies with lung cancer SMRs
>2 have >1% mesotheliomas. Somewhat
less credence is given to these expos-
ure-response trends than to the trends
evaluated within individual studies where
exposure is more quantitative.
Cohort studies are useful for evaluating
the risk ofdisease associated with work in a
particular industry and/or exposure to spe-
cific substances. This is because the cohort
is defined by exposure status, or more cor-
rectly, by employment status within an
industry. The results of such a study may
not be conclusive for a variety of reasons:
1) dilution of exposed workers by less
exposed/nonexposed workers, 2) lack of
information on confounding exposures
and nonoccupational risk factors, or 3)
lack ofinformation on magnitude ofexpo-
sure.
In 1964, Selikoff et al. (1) reported a
threefold excess ofcancers ofthe stomach,
colon, and rectum among 632 asbestos
insulation workers (29 observed/9.4
expected). There was a 6.8-fold excess of
cancer ofthe lung and pleura.
There are at least 19 cohort studies
since then that have reported SMRs for
lung cancer and colorectal cancers among
asbestos workers (or workers exposed to
asbestos) with 10-20 or more years of
latency. These are listed in Table 6 and
graphically displayed in Figure 1. The orig-
inal cohort of insulation workers was fol-
lowed up by Selikoff et al. (30) and is
included in Figure 1. These data are not
included in the meta-analysis because they
should not be part ofthe data used to test
the hypothesis of whether asbestos causes
CRC. That is, an initial study that gener-
ates a hypothesis should not be used to test
that same hypothesis. Studies are included
that have reasonably complete follow-up
(>90%) and either colon cancer or CRC
deaths are listed. Only the last update ofa
study was included ifmore than one report
had been published.
In the high lung cancer exposure group
(SMRs >2), there are seven eligible
cohorts. All but two have SMRs for CRC
>1; the overall SMR for CRC is 1.48
(1.21, 1.78). In the low lung cancer expo-
sure group (SMRs <2), there are 12 eligible
cohorts; 5 studies have SMRs for CRC >1
(1 is significant), and 7 have CRC SMRs
<1 (2 are significant). The overall SMR for
CRC for this exposure group is 0.95 (0.84,
1.05).
The low-exposure cohort with the
highest and only statistically significant
SMR for CRC (2.3) comprises production
and maintenance workers at a calcium car-
bide plant in Norway where there was
exposure to polyaromatic hydrocarbons,
volatile coal-tar-pitch products, and cadmi-
um as well as asbestos (36). Asbestos had
been used regularly in past years for insu-
lating material around furnaces with some
use in the mechanic shop. Because there
was no definite excess oflung cancer (SMR
= 1.15), the authors were reluctant to sug-
gest asbestos as a possible causal agent for
CRC. They also suggest some statistically
significant associations could be chance
given the large number ofcomparisons.
The Swedish study of asbestos cement
workers (45) had a statistically nonsignifi-
cant SMR of 1.5 for CRC. Exposure was
mainly to chrysotile, with smaller amounts
ofcrocidolite and amosite. There was a sig-
nificant excess ofpleural mesothelioma (13
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Table 6. Summary of standardized mortality ratios (SMRs) for lung cancer, colon cancer, and colorectal
cancer among asbestos-exposed cohorts (latency.20 years unless noted otherwise)
Observed/expected = SMR (95% Cl)
Lung cancera Colon cancer Colorectal cancer Reference Exposure (type of asbestos)
SMR<2.0
0.99(NR) 52/44.5 = 1.17
(0.87, 1.52)
1.05 (0.5%) 15/20.9 = 0.72
(0.39, 1.14)
1.15 (NR) 12/5.2 = 2.31
(1.17,3.8)
1.17 (0.2%) 10/8.3 = 1.20
(0.56, 2.09)
1.25 (0.2%) 79/101.3 = 0.78
(0.61, 0.97)
1.36 (4.1%) 5/15.4 = 0.33 14/27.4 = 0.51
(0.10, 0.68) (0.27, 0.82)
1.44(1.4%) 13/16.7 = 0.78
(0.41, 1.27))
1.44(0.8%) 11/15 = 0.73
(0.36, 1.24)
1.44(3.2%) 5/6.34 = 0.79
(0.24, 1.65)
1.71 (0.3%) 7/13.4 = 0.52 23/24.8 = 0.93
(0.21, 1.08) (0.58, 1.35)
1.8 (2.2%) 26/17.3 = 1.5
(0.7,3)
1.83(0.8%) 32/30.16 = 1.06 67/57.9 = 1.16
(0.73, 1.5) (0.89, 1.46)
Total (0.8%) 44/58.96 = 0.75 327/345.64 = 0.95
(0.54,0.99) (0.84, 1.05)
SMR .2.0
2.41 (1.5%) 2/1.46 = 1.37
(0.17, 4.9)
2.71 (0.8%) 14/14.24 = 0.98 23/19.9 = 1.16
(0.53, 1.58) (0.72, 1.69)
3.47 (4.2%) 3/1.39 = 2.15
(0.39, 5.4)
3.88 3/3= 1.0
(all causes NR) (0.18, 2.5)
4.0 (7.1%) 1/1.3 = 0.77
(0,3.1)
54/34= 1.59
(1.29, 2.05)
22/11.9 = 1.85
(1.14, 2.7)
108/72.95 = 1.48
(1.21, 1.78)
(35) Maintenance; ferroalloy industry;
PAH; SiO2;asbestos (.15years L)
(40) Swedish railroad shopworkers
(Am, Cr, Ch)
(36) Calcium carbide plant; maintenance
workers; PAH, Cd (.15 years L)
(41) Asbestos cement(Am, Cr)
(42) Chrysotile mining
(32) UK asbestos workers (.10 years L)
(43) UKtextiles (Ch, Cr)
(41) Asbestos cement (Ch, Cr)
(44) German asbestos workers, .3
years before 1977
(33) Norwegianshipyard(Ch)(.10years L)
(45) Swedish asbestos cement
(Ch, Cr, Am)
(37) Danish asbestos cement
(Ch,Am, Cr)(.15 years L)
(38) Insulation board UK(Am), approxi-
mateto exposures in Selikoff(1)
(.15years L)
(34) Retired asbestos workers, USA
(44) German asbestos workers
working priorto 1972
(46) Production and maintenance
workers, HNO3plant in Norway
(47) Swedish maintenance workers
ferrochromium plant(Cro, Cr3+,
asbestos)
(30) USA, Canada insulation workers
(Cr,Am)
(48) NJ amositefactorymaking
insulation for navy(5-40years L)
Abbreviations: Cr, crocidolite; Am, amosite; Ch, chrysotile; NR, not reported; L, latency.
aPercent mesotheliomas (number mesotheliomas/total deaths) are in parentheses.
cases of 592 deaths and an SMR of 7.2)
and nonmalignant respiratory disease (56
cases and an SMR of 2.6). The SMR for
lung cancer was 1.8 but was not statistical-
ly significant. There was "no overall risk"
from cancer in the upper or lower gastroin-
testinal tract, although there was an expo-
sure-response relationship between CRC
and cumulative fiber exposure, but not
between CRC and tenure. The authors
suggest the "overrisk ofcolorectal cancer in
highly exposed workers might be due to
cement exposure" (45). This speculation is
based on an excess of rectal cancer in a
cohort of cement workers and an overrep-
resentation of cement workers in a unpub-
lished study of CRC. Jakobsson et al. (49)
found an odds ratio of 3.2 for blue-color
cement workers with >25 years tenure, a
finding supporting a cement rather than
asbestos etiology. Thus, no studies of
asbestos-exposed workers with lung SMRs
<2 were found that showed an appreciable
or convincing increased risk of CRC that
could not also be attributed to chance or
confounding exposures.
Hill (8) and others argue that an expo-
sure-response relationship in an observa-
tional study gives support to a causal expla-
nation for a disease-exposure association.
Exposure-response relationships have been
observed for lung cancer. On the basis of
nine published studies of asbestos workers
where individual exposure was estimated,
Browne (50) suggested that there is a
threshold of increased risk of lung2cancer
in the range of 25-100 fibers/cm -years.
The larger database on CRC suggests that
ifthe lung SMR is <2, there is probably no
increased risk of CRC. In the exposure
group where lung SMRs are >2, only two
of seven studies clearly show a large
increased risk ofCRC.
One can further evaluate expos-
ure-response relationships within the same
study and between studies where workers
are stratified by some measure ofexposure.
The exposure measures available in as-
bestos cohorts for both lung cancer and
CRC are million particles per cubic foot
(mppcf)-years (41,42), length of exposure
(32,41,43), and fiber-years/ml (45) (Table
7). Hughes et al. (41) found no apparent
exposure-response association for either
lung cancer or CRC. Albin et al. (45)
found no apparent exposure-response
association for lung cancer. For CRC there
was an apparent association, with an SMR
of 3.4 in the >40 fibers-years/ml category,
but no increased SMR in the lower expo-
sure categories. The remaining four
cohorts show an exposure-response trend
for lung cancer, but no trend for CRC.
Figures 2-5 display the SMRs for lung
cancer and CRC by exposure category.
Lung cancer SMRs are significantly above
the no-effect level for .15 years tenure and
.150 mppcf-years. CRC SMR point esti-
mates are at or below the no-effect level
over the same range ofexposures, although
the confidence intervals are generally quite
wide, and only one is statistically signifi-
cant.
A trend is also observed ifthe SMRs for
lung cancer and CRC are combined for the
low-, medium-, and high-exposure cate-
gories for all six studies in Table 7 [mppcf-
years used for plant 2 (41)]. The Albin et
al. (45) study was not included because
observed and expected deaths were not pro-
vided. These exposure-response trends
from Table 7 are combined in Table 8.
The advantage of these analyses is that
the exposure-response association for lung
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cancer and asbestos exposure is less likely
to be confounded by cigarette smoking,
and there is less likelihood ofexposure mis-
classification. These data indicate an expo-
sure-response relationship for lung cancer
but not CRC and indicate that mortality
from lung cancer is elevated at higher
exposure levels, but mortality from CRC
in the same cohorts and at similar exposure
levels is not elevated.
Colon Cancer and Occupation:
Case-Control Studies
A nested case-control study (colon cancer
cases/controls from a cohort of asbestos
workers) is potentially the most appropri-
ate and efficient study design for determin-
ing causality, but none was found.
Several population-based case-control
studies are summarized in Table 9. A weak-
ness ofthis study design is that a number of
occupational exposures are evaluated in one
study. It is difficult to obtain good occupa-
tional histories, and the prevalence ofexpo-
sure is often low (52). Several results can
occur, including too few exposed subjects to
analyze, and a negative result that may or
maynot be reported. The lackofan observed
association maybe due to exposure misclassi-
fication, confounding, too low an exposure,
and/or no true association. A false positive
association is possible, for example, because
ofconfounding occupational and/or nonoc-
cupational exposure andsamplingvariability.
Hardell (51) reported a 1.9-fold excess
10
EE
= 11 _U |
U _ i
.5 -g
U
S _0 I_ X.5 eU |
0.1 I
0.9 1.0 1.1 1.1 1.513_.414 .417 .818 U .127 .138 eJ~~~~~~~~~~M fo lun cane
Fiur 1. Ris of cooetlcne nabso oreswt 2 er fltny
odds ratio (OR) among Swedish men
exposed to asbestos. Other than matching
on age and place ofresidence, there was no
control for potential confounders nor con-
sideration ofdegree ofexposure. Spiegelman
andWegman (1X4 used data from the Third
National Cancer Survey to generate
hypotheses about colon cancer and occupa-
tional exposure. Using the NIOSH Hazard
Survey, they calculated a cumulative expo-
sure probability score (probability of expo-
sure and years worked) for each case and
control. They found no apparent excess
when comparing medium-high exposure
versus low asbestos exposure scores for males
and low-medium versus high exposure for
females and controlling for potential con-
founders. Fredriksson et al. (20) reported a
twofold excess risk for Swedish males and
females exposed to high-grade asbestos and
no apparent risk when exposure was to low-
grade asbestos. High and lowgrade were not
Table 7. Exposure response for colorectal cancer and lung cancer by exposure among asbestos cohorts
Cumulative exposure
<30 mppcf-years
30-300 mppcf-years
.300 mppcf-years
<10years
>10 years
<1 year
1-5years
5-15years
.15years
<1 year
1-5years
5-15years
.15 years
<6 mppcf-years
6-24 mppcf-years
25-49 mppcf-years
50-99 mppcf-years
.100 mppcf-years
<15fibers-years/mI
15-39fibers-years/mI
.40fibers-years/mI
<10yearsa
.10yearsa
.20yearsa
Observed/expected = SMR (95% CO)
Lung cancer Colorectal cancer
91/97.8 = 0.93 (0.75, 1.14) 34/54.84 = 0.62 (0.43,0.85)
81/68.6 = 1.18 (0.93, 1.46) 28/36.36 = 0.77 (0.51, 1.09)
70/31.1 = 2.25 (1.74, 2.82) 18/16.2 = 1.11 (0.65, 1.70)
53/45.4 = 1.17 (0.87, 1.51) 8/11.8 = 0.68 (0.28, 1.24)
40/19.1 = 2.09 (1.48, 2.81) 5/4.86 = 1.03(0.31, 2.15)
32/24 = 1.33(0.90, 1.85) 4/4.6 = 0.87 (0.22, 1.96)
6/8 = 0.75 (0.26, 1.49) 4/1.7 = 2.38 (0.59, 5.29)
4/3.5 = 1.15 (0.29, 2.57) 1/0.8 = 1.2(0, 5)
6/5.7 = 1.05 (0.37, 2.09) 1/1.2 = 0.81 (0, 3.3)
55/45.5 = 1.21 (0.90, 1.56) 5/9.3 = 0.54(0.16, 1.13)
20/14.4 = 1.39(0.84, 2.08) 1/2.8 = 0.36(0, 1.42)
8/3.6 = 2.24(0.93,4.07) 0/0.7 = -(0, 1.43)
24/10.9 = 2.2(1.39,3.19) 3/2.1 = 1.4(0.26, 3.55)
20/18.9 = 1.06(0.64, 1.58) 2/3.9 = 0.51 (0.04, 1.49)
19/14.5 = 1.31 (0.78, 1.98) 1/2.8 = 0.36 (0, 1.43)
12/6 = 2.0 (1.01, 3.32) 0/1.2 = -(0, 0.83)
10/5/5 = 1.81 (0.85,3.15) 3/1.1 = 2.73 (0.49,6.79)
12/5.2 = 2.31 (1.17, 3.83) 0/1 = 0(0,1)
1.8 (0.8, 3.9) 1.3 (0.5, 2.9)
1.9 (0.7, 5.3) 1.1 (0.3, 3.9)
1.9 (0.5,7.1) 3.4(1.2, 9.5)
40/43.3 = 0.92 (0.65, 1.24) 1/2.5 = 0.40 (0, 1.60)
145/102.8 = 1.41 (1.19, 1.65) 2/5.5 = 0.36 (0.03, 1.06)
3/5.6 = 0.35 (0.10, 1.33)
Exposure and reference
Chrysotile mining (42)
Textiles (43)
Plant 1, asbestos cement(41)
Plant 2, asbestos cement(41)
Plant 2, asbestos cement(41)
Asbestos, cement (45)
UK asbestos workers (32)
mppcf-years, million particles per cubic foot-years.
NYears before 1969.
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defined, and the OR is based on a dichoto-
mous classification ofexposure. Adjustments
were made for age, sex, and physical activity.
Siemiatycki (52) reported on the asso-
ciation between 183 substances and 11
types ofcancer at two exposure levels clas-
sified as any exposure and substantial expo-
sure. Subjects were from the Montreal area
with cancer controls and a smaller group of
population controls. Potential confounders
controlled for in the colon cancer analyses
were ethnic origin and beer consumption.
There were no apparent ORs associated
with exposure to inorganic insulation dust,
amphibole asbestos, or chrysotile asbestos.
The authors did not include the associa-
tion ofasbestos and colon cancer as priori-
ties for further investigation.
Gerhardsson de Verdier et al. (53)
reported on a population-based case-con-
trol study in Stockholm. Elevated risks
were observed among males exposed to
asbestos, and there was little difference
between adjusted and unadjusted ORs.
About one-third of the asbestos-exposed
cases were also petrol/auto-repair workers, a
group also showing elevated ORs. Because
of the small numbers of exposed subjects
and high correlation between risk expo-
sures, the authors could not separate out
the effects ofsingle exposures. They suggest
the potential for simultaneous exposure to
several occupational risk factors should be
considered in other investigations.
Garabrant et al. (54) found no associa-
tion between asbestos exposure and colon
cancer in Los Angeles County, California.
They found a weak association in a uni-
variate analysis, but when adjusted for con-
founding factors, the association disap-
peared, reducing the overall OR 15-20%.
Exposure-response was evaluated by sever-
al measures, including frequency of expo-
sure, duration ofexposure, and cumulative
exposure, with none showing any trend.
The authors concluded that in this popula-
tion asbestos is not a risk factor for colon
cancer, and it is important to control for
nonoccupational risk factors before inter-
preting an observed association as causal.
These case-control studies do not pro-
vide much support for a causal association
between asbestos exposure and colon can-
cer. The two studies with nearly twofold
excess risk have either not controlled for
potential confounders (51) or have other
correlated occupational risk factors (53).
The other studies show no apparent associ-
ation at all. One reason for the lack of an
association could be an exposure that is too
low to have a measurable effect. It seems
unlikely that cases in the high-exposure
group in the study by Garabrant et al. (54)
have exposures of the magnitude produc-
ing twofold or higher excess lung cancer
deaths seen in asbestos cohorts. For exam-
ple, there were only 11 of66 cases report-
ing exposure to asbestos who were likely to
have exposures of this magnitude (i.e., 6
insulation workers and 5 workers in ship-
building/repair). The results ofthese stud-
ies are not inconsistent with studies of
asbestos cohorts, which indicated at most a
slight increased risk of CRC when expo-
sure to asbestos was very high. However, it
is not possible to compare exposure levels
between studies or even between individu-
als in the same study. Two studies (53,54)
show how uncontrolled confounding from
other jobs not involving asbestos exposure
as well as nonoccupational risk factors can
spuriously elevate risk ratios and make
causal inferences more difficult.
Biological Plausibility
Is it plausible that asbestos causes colon
cancer? Are there increased colon tumors
in animals exposed to asbestos?
Condie (55) reviewed 11 animal stud-
ies oforally administered asbestos. At least
4 were not lifetime studies, and in 9 of 11
studies the rat was the experimental ani-
mal. In only two of the studies (56,57)
were there any colon cancers. Rats were fed
10% chrysotile in the diet ad libitum for
32 months. The incidence ofcolon tumors
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Figure 2. Exposure-response for lung cancer among asbestos cohorts by million particles per cubic foot-
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Figure 3. Exposure response for colorectal cancer among asbestos cohorts by million particles per cubic
foot-years.
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was 1.6%. The incidence in the group fed
10% cellulose fiber was 1% and incidence
in the control group was 2.6%. Thus the
number of colon tumors from asbestos
ingestion was not increased compared to
controls (56).
In the other experiment, rats were
exposed to azoxymethane and/or asbestos
for 10 weeks and followed for 34 weeks or
a lifetime in two separate experiments (57).
In the shorter experiment, exposure to
amosite and chrysotile produced no
tumors. In the lifetime study the incidence
ofcolon tumors was 56% when exposed to
azoxymethane, 60% when exposed to
azoxymethane plus amosite, and 33%
when exposed to saline plus amosite. There
was no control group, and the incidence of
Table8. Exposure-response trendsfrom low, medium, and high exposure categoriesfrom Table 7
Low Medium High
Lung cancer
Observed: SMR 236:1.03 132:1.24 273:1.67
(95% Cl) (0.90,1.17) (1.04,1.47) (1.47,1.87)
Colorectal cancer
Observed: SMR 49:0.63 37:0.84 29:0.84
(95% Cl) (0.46,0.82) (0.59, 1.14) (0.56, 1.19)
SMR, standardized mortality ratio.
zymbal gland tumors was 14% in the
amosite lifetime exposure group. Zymbal
gland tumors are rare (-0.3%), and both
intestinal carcinomas and zymbal gland
tumors are induced by a single dose of
azoxymethane. An inadvertent exposure to
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Figure 4. Exposure response for lung cancer among asbestos cohorts byyears worked.
10
Ln
cc
2
U,
a,
0.1
0.01-
0.3 0.6 2.5 3.5 4 6 9 11 15 18 19 21
Yearsworked inotto scale)
Figure 5. Exposure response for colorectal cancer among asbestos cohorts byyears worked.
azoxymethane may have caused the
increase in the amosite-exposed group.
From his review, Condie (55) con-
cludes that "long-term, high level ingestion
exposure to various types ofasbestos fibers
failed to produce any definite reproducible,
organ-specific carcinogenic effect," and in
particular no effect specific to the colon.
Ingestion is considered relevant to humans
because exposure may occur by swallowing
fibers cleared from the lung.
There have been at least three long-
term ingestion studies since the review by
Condie. McConnell et al. (58) reported on
a study that overcomes the criticisms
regarding asbestos ingestion studies with
respect to the small number ofanimals and
the less-than-lifetime length of the study.
Groups of250 male and 250 female F344
rats were fed 1% amosite over their entire
lifetime and compared to control groups of
over 100 animals each. There was some
increase of thyroid cancer and monocytic
leukemia in the male rats. These effects
were discounted by the authors, who ques-
tioned the biological significance of the
cancers. No toxic or neoplastic lesions were
observed in the gastrointestinal tract or in
the mesothelium.
McConnell et al. (59) also reported on
a similar lifetime study ofhamsters fed 1%
amosite, short-range chrysotile, or interme-
diate range chrysotile in the diet. The
results were statistically the same in the
exposed and control groups. There were no
adverse effects on body weight gain, sur-
vival was enhanced, and there was no
increase in number oftumors. There were
increases in adrenal tumors in male and
female hamsters exposed to intermediate-
range chrysotile asbestos, but the biological
significance was questioned.
Truhaut and Chouroulinkov (60) fed
male and female rats daily doses of 10, 60,
and 360 mg ofa mixture ofchrysotile/cro-
cidolite in palm oil for two years.
Observation continued for an additional 6
months. There was no sign oftoxicity and
no adverse effect on survival or body
weight. There were no statistically
detectable differences in tumor incidence
between exposed and controls, no expo-
sure-response relationships, and no gas-
trointestinal tumors.
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Table 9. Summary of population-based case-control studies of asbestos and colon cancer
Source of cases/controls No. of cases/controls OR (95% Cl) Reference Comments
Swedish Cancer Registry 16/137 1.9 (1.0, 3.6) (51) No information on latency, duration, intensity of
(1978-1979)/population exposure; no apparent control of nonoccupa-
in same region tional riskfactors
Third National Cancer Survey Males 850total 1.22 (p= 0.33) (12) Exposure based on job title and classification
(cancer controls) Females 1406total 1.09 (p= 0.64) from NIOSH hazard survey of dichotomous(high
vs. low) exposure analysis; control for
confounders (including dietand weight)
Cases from Swedish Cancer 329/658 High-grade asbestos: (20) Stratified by age, sex, and physical activity index
Registry (1984-1986); controls from (male and female) 2.1 (0.8,5.8); score in analysis
population registry; both residents low- grade asbestos:
of Umea 1.2 (0.6, 2.4)
Montreal metropolitan area Any (52) 90% Cl
54a Inorganic insulation dust 1.2 (0.9, 1.5)
34 Amphibole asbestos 1.2 (0.8, 1.7)
78 Chrysotile asbestos 1.0(0.8, 1.3)
Substantial
20a Inorganic insulation dust 1.6 (1, 2.5)
4 Amphibole asbestosl.0 (0.4, 2.1)
18 Chrysotile asbestos 1.6 (1, 2.5)
Stockholm residents, 22/20 1.9(0.9,4.2) (53) Adjusted for age,total energy, fat, protein, and
1986-1988; males fiber intake, physical activity, body mass, family
history of colon cancer
Los Angeles tumor registry Cumulative exposure (freq xduration) (54) Maleswith.15 years latency; adjusted for
and neighborhood controls Never (343/361) 1.0 family history of colon cancer, diet, weight, and
1-30 (36/31) 1.07 (0.63, 1.8) physical activity; unadjusted ORs were higher
31-60 (10/8) 0.94(0.33, 2.65) than adjusted values
>61 (11/11) 0.55(0.21, 1.47)
OR, odds ratio.
aNumber of exposed cases.
Bolton et al. (61), in addition to find-
ing no colon tumors in a lifetime study of
rats ingesting amosite, crocidolite, or
chrysotile, found "no evidence of wide-
spread penetration of, or damage to, the
gastrointestinal mucosae." They used the
scanning electron microscope and could
detect fibers >0.1 pm in diameter. Ofpar-
ticular note was the absence offibers in the
mesenteric lymph nodes, where concentra-
tion of fibers would be expected if fibers
penetrated the mucosae. No evidence of
either intestinal damage or changes in cel-
lular proliferation was observed.
A number of investigators have exam-
ined the penetration of asbestos into cells
and tissues, assuming that a large number
offibers must penetrate the gastrointestinal
mucosa to lead to carcinogenesis. Cell
membranes appear to be resistant to pene-
tration by sharp mineral fibers, and most
fibers seen in cells are enclosed in phago-
cytic vacuoles or phagosomes (62). Rarely
are fibers seen in cells other than phago-
cytes, and free fibers in nonphagocytes may
be an artifact of the preparation (61).
Penetration of the surface membrane of
the gut may be particularly difficult
because ofthe closely packed brush border,
the longitudinal bundles projecting from
the base of the brush border to form the
"terminal web," and the close apposition of
gut epithelial membrane attached by
desmosomes (62). In addition, the mucous
coating of the gut epithelium may help
limit contact ofthe fiber with the gut wall
and therefore inhibit penetration.
Cook (63) reviewed available studies
investigating fiber accumulation in tissues
and body fluids after ingestion of asbestos
fibers. Cook does not condude that asbestos
fibers do not cross the intestinal barrier, but
suggests the data indicate that only a small
fraction offibers penetrate the gut wall and
that there is a "low probability for signifi-
cant tissue accumulation and increased risk
ofcancer." Meek (64) reaches essentially the
same conclusion and points out additional
factors that complicate interpretation ofthe
evidence. These include a lack ofcharacteri-
zation of the analytic methods used to
examine the tissues; possible contamination
from external sources; use of thin samples
rather than bulk tissue residues, therebylim-
iting the area searched as well as creating
possible artifacts by thin section prepara-
tion; and no conclusive confirmation ofbio-
logical response associated with penetration.
The last factor was investigated further by
Meek (64). He showed that injecting
amosite into the gut wall produced a short-
term tissue response including granulomas
characterized by dense masses of macro-
phages. However, 5 days after administra-
tion ofamosite for 5 days there was no evi-
dence ofa macrophage response.
For asbestos to induce a neoplastic
process, it is generally assumed that the
fiber must penetrate the cell wall, and in
the case of colon cancer, penetrate the
mucosa of the colon. Donham et al. (56)
tried to answer two questions: 1) is some
minimum fiber penetration is necessary to
cause cancer, and 2) if fiber penetration
does occur, do fibers act as direct carcino-
gens, tumor promoters, or cocarcinogens?
To answer these questions, they X-irradiat-
ed localized segments ofthe colon, divided
two strains of rats into three groups, and
fed them a standard lab diet, a diet con-
taining 10% cellulose, or a diet of 10%
chrysotile. The X-irradiation produced a
localized disruption of the colon with
ulcerations, dysplasia, and chronic inflam-
mation. At the irradiated sites there were
four tumors in the rats fed cellulose, three
tumors in the rats fed asbestos, and no
tumors in the group fed the normal diet.
The differences were not statistically signif-
icant, even if the asbestos and cellulose
groups were combined. The histologic
appearance of the tumors resembled those
produced by X-rays alone. The number of
animals studied was small (47 Holtzman
rats and 90 Fisher rats), and further studies
were recommended. These authors con-
clude that studies to date "indicate ingest-
ed asbestos may have only a weak effect, if
any, with respect to development of
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epithelial cancers of the large bowel" and
that asbestos "does not seem to be co-car-
cinogenic or a tumor promoter in combi-
nation with disruption of mucus coating
and localized X-irradiation." There was
also no difference between treatment
groups in colon lesions including dysplasia,
ulceration, chronic inflammation, and pro-
liferative hyperplasia.
Patel-Mandlik and Millette (65) report
data that appear somewhat contradictory.
They used transmission electron micro-
scopy (TEM) to assess the accumulation of
asbestos fibers in the kidney cortex of four
groups of rats gavaged twice weekly with 50
mg/kg of intermediate-range chrysotile
asbestos. There was increased fiber recovery
in 17 ofthe 20 exposed rats, a finding con-
sistent with the passage ofchrysotile across
the gut wall. The length distribution ofthe
recovered particles was highly skewed, with
97% being <3.1 pm long. Thus there were
very few particles longer than 5 pm, the
federal criteria used to count asbestos.
Diameter ofthe particles was not measured,
but small fibers were detectable as TEM
was used and fibrils as well as bundles and
clusters were counted. The biological sig-
nificance ofthese very small particles is not
clear. Other evidence (such as implanta-
tion) show that these size particles do not
produce tumors and may not be toxic (66).
A possible early indicator of neoplastic
transformation is increased cell prolifera-
tion, which can be measured as an increase
in DNA synthesis. Amacher et al. (67)
administered chrysotile to rats by gavage
and observed increased DNA synthesis in
the stomach, small intestine, and colon, but
not in the liver. The increases occurred at
different time intervals: 1 day after dosing
in the stomach, 7 days in the small intes-
tine, and 28 and 63 days after dosing in the
colon. However, these results do not appear
to correlate with tumor incidence in life-
time studies, as no increased tumors are
seen in these organs.
In summary, the lifetime exposure of
animals to asbestos in the diet shows a con-
sistent lack of colon (or even GI) tumors,
even when the colon wall is damaged.
Table 10 summarizes the experimental data
on bioassays regarding the biological plausi-
bility ofasbestos causing colon cancer. The
one observation supporting the hypothesis
is increased cell proliferation as measured
by DNA synthesis.
Ehrlich et al. (68) examined the
asbestos burden of44 asbestos workers with
colon cancer. Asbestos fibers and/or bodies
were not present in 30 of44 (68%) of the
colon tumors and were present in 32%.
Normal colon tissue was also examined in 9
of 14 cases, and asbestos bodies and/or
fibers were found in 2 ofthe 9. These data
indicate asbestos does enter and reside in
the colon wall of a minority of asbestos-
exposed workers with colon cancer and
may be associated with the tumor tissue.
However, fibers appear to be associated
equally with normal tissue and tumors.
Tissues of asbestos-exposed workers with-
out colon cancer were not examined.
Corroborative evidence relevant to
ascertaining a human colon cancer risk is
generally either not available or does not
show the effects observed in the lung (Table
1 1). Both genotoxic and nongenotoxic
mechanisms are applicable to humans, and
in the lung both may be operative. It is not
clear that either occur in the GI tract. In the
colon there are no data adequate to show
long-term cell proliferation. Some genotoxic
effects ofasbestos have been shown in some
cell types in vitro but to less of an extent
than chemical carcinogens. None were
found for cells from the gut epithelium.
Table 10. Bioassay observations relevantto ascertaining human colon cancer riska
Supportive
Same route of administration as in humans is important for drawing inferences
about human hazard.
Activity in several species makes it more likely a similar response will be present
in humans.
Tumor-site correspondence across species increases confidence that an effect
is notspeciesspecific and unrelated to humans.
Activity at several sites increases likelihood humans will show a similar response.
Targetsites common to humans. Tumors in nonhuman organs are unlikely
to be predictive.
1% asbestos in diet during entire lifetime of rats and hamsters produced
no clinical signs oftoxicity, decreased survival, ortumors. Tumors observed
when there is no othertoxic effect are considered more likely to occur in humans.
Genotoxic carcinogens generally induce tumors early; often they progress
rapidly and cause death.
Increased tumors at several exposure levels implies a greater probability
of hazard to humans.
Background rate of colon cancer in animals is low.
Induced cell proliferation may promote development oftumors from initiated cells.
A dose of 100 mg/kg chrysotile increased cell proliferation as measured by
DNA synthesis 1.5times or less from 28 to 63 days after exposure, and is suggestive
ofthe potential for nongenotoxic mechanism.
Nonsupportive
Humans are exposed via inhalation, with subsequentclearance
andswallowing. Animals are exposed via ingestion. Exposure via
inhalation results in fewerlong fibers in gut Adsorption ofsurfactant
reduces hemolytic activityofasbestos. Toxicityisreducedforshorter
fibers.
Ingestion studies have notconsistentlyshown activityin rat or
hamster.
Inhalation ofasbestosproduces fibrosis, bronchial carcinomas, and
mesothelioma (mainlyin rats), butnotgastrointestinal cancers.
Lifetime exposure via dietoflarge numbers ofanimalsshowedadrenal
cortical tumors in male hamsters and thyroid tumors andleukemia in
male rats. Neither was consideredsignificant Inhalation exposures
thatproduce lung cancer, mesothelioma and fibrosis do notinduce
GI tumors.
14% incidence ofzymbalgland tumors in rats exposed to amosite,
probably due to exposure to azoxymethane.
Tumors appearing under conditions causing toxicity are considered
less likely to predict a human response. The offspring of mothers fed
1% asbestos in diet were smaller atweaning and later, but no clinical
effects ortumors.
There appearto be no increased tumors, andmortalityis unaffected
byasbestos ingestion.
As much as 5% asbestos in the diethas notproduced anyincreased
tumorincidence.
Cellproliferation is at a high rate, so inherentmechanisms mustexist
to repairgenetic damage oreliminate altered cells before cancer
progression can occur.
No hyperplasia was observed in a lifetime ingestion study and is not
supportive of a nongenotoxic mechanism.
Volume 102, Number 12, December 1994
aRegulartype indicates the criteria being assessed. Italic type indicates thatthe weight ofthe evidence favors that criteria. If both column entries are in regular
type, it indicatesthatthe evidence is contradictory as to whetherthose criteria are supportive ofthe hypothesis.
1047I9 -, 9.
Table 11. Nonbioassay corroborative observations relevantto ascertaining human colon cancerhazarda
Supportive Notsupportive
Themechanism ofaction atthe cellularlevelis applicable tohumans. Mechanism not relevantto humans.
Agent causes mutations. Asbestos doesnotappearto cause mutationsin mostcelltypes.
Asbestosinduces chromosomal changes which mayactivate a gene that Genotoxic effects specific to certain celltypes andevidence notclear
transforms a cellinto animmortalneoplastic condition orinactivate as to occurrence in epithelialcellsofcolon.
tumor-suppressorgenes thatsuppress cellproliferation in vivo.
Asbestos induces lung cancer and mesothelioma, buta difference in Exposure toacidinstomach changessurface charge, mayleach outions
surface charge and longer residence time than inthe GI tract. thatare required forfibertoxicity; clearance isshorterandnotdependent
onphagocytic macrophages.
Hyperplasia in the target organ before tumor development suggests No increased non-neoplastic diseases of the GI tract (enteritis, ulcera-
tion, a nongenotoxic mechanism ofcarcinogenesis. inflammation) and nohyperplasia have been notedinlong-termstudies.
aRegulartype indicates the criteria being assessed. Italic type indicates the weight ofthe evidence favors that criteria. If both column entries are in italic type, it
indicates the observed effects are contradictory and are both supportive and notsupportive.
Table 12. Effect of epidemiologic and experimental data on the hypothesis that asbestos causes colon
cancera
Criterion Support Detract Indeterminate
Time order: >10-20years latency +
Compatible
Strength of association
Lung cancer SMR <2-no association +
Lung cancerSMR >2-weak association +
(possible positive bias from misdiagnosis)
Presence of biological gradient
Exposure-response trend for lung cancer ++
but not colorectal cancer
(exposure = mppcf/years)
Slight increase in SMRs when lung cancer +
SMRs >2(possible positive bias from
misdiagnosis)
Consistency
No orweak association +
Biological gradient(all studies) +
Biological plausibility
Lung cancer,yes ++
Colon cancer, no ++
mmpcf-years, million particles per cubic foot-years.
"Overall conclusion for colon cancer: Low asbestos exposure: evidence of noncarcinogenicity in both
humans and animals. High asbestos exposure: possible colon cancer carcinogen based on limited evi-
dence in humans using surrogate measure of exposure, but probable disease misclassification bias. No
evidence of carcinogenicity in animals and lack of exposure response within studies considered
strongest evidence against colon carcinogenicity.
Genotoxic effects may be less likely to occur
in the gut compared to the lung because of
the preponderance ofshorter fibers, shorter
residence time, greater protective features,
and shorter exposure time.
Summary
Table 12 summarizes the evidence evaluat-
ing the hypothesis that asbestos causes colon
cancer, using well-known criteria for deter-
miningwhetheran association is causal.
The potential confounding effect offour
nonoccupational risk factors was not con-
sidered to significantly bias the results ofthe
epidemiologic studies. The risk from alco-
hol consumption and smoking is negligible,
and so these factors cannot bias the results.
Obesity modestly increases risk, and physi-
cal activity is somewhat protective.
However, the potential confounding effect
is considered minimal. Misdiagnosis is likely
to bias the risk estimates so the SMRs for
colon cancer are spuriously elevated. Use of
the combined colon and rectal cancer
instead ofjust colon cancer also appears to
overestimate risk.
The evaluation of human risk was
largely confined to studies where the risk
of colon or colorectal cancer was deter-
mined among workers for whom 10-20 or
more years had elapsed since date ofhire, a
surrogate measure ofdate offirst exposure.
It is thought likely that among this group
there is sufficient time to ascertain the
occurrence of disease caused by exposure,
as the occurrence ofdisease earlier than 20
years since first exposure is likely due to
some other causes.
Among asbestos workers with lower
exposures, as measured by the risk ratio for
lung cancer, there is no apparent increased
risk of colorectal cancer. Among asbestos
workers with higher exposure (lung cancer
SMR >2), there is about a 50% increase in
colorectal cancer. The consistent lack ofan
association at lower exposures detracts
from the hypothesis. The weak association
at higher exposures is considered to be
indeterminate because of the possibility
that misdiagnosis was the reason for the
increased colorectal cancers. The reduction
in SMRs for colon cancer compared to col-
orectal cancer observed in five studies
where both were presented further weakens
the case for a casual relationship for colon
cancer.
The overall evidence from within indi-
vidual studies suggests there is no biologi-
cal gradient. Although there are few studies
assessing exposure response and the esti-
mates ofexposure are poor, there is a con-
sistent finding of an exposure-response
trend for lung cancer (five of seven stud-
ies), and an equally consistent finding of
no apparent exposure-response trend (six
ofseven studies) for CRC. The lack ofany
consistent findings showing clear expo-
sure-response relationships detracts from
the hypothesis.
None of these cohorts have informa-
tion on colon cancer risk factors such as
diet, obesity, or physical activity, so possi-
ble confounding cannot be assessed direct-
ly. Most ofthe occupations do not appear
to be sedentary. Whether these factors have
reduced the SMRs is not known, but
because the association is not strong, the
potential confounding effect is considered
minimal.
The animal studies are consistently
negative in showing no increase in colon
tumors and no increase in mortality or
morbidity in at least two species. The find-
ing of increased cell proliferation in the
colon after asbestos dosing suggests several
possible interpretations including a possi-
ble nongenotoxic mechanism, cytotoxic
dose, and or mechanisms to repair damage.
Based on animal studies, it is not biologi-
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cally plausible that asbestos exposure
would cause colon cancer in humans
exposed via inhalation and at much lower
concentration levels. These data detract
from the causal hypothesis.
Corroborative evidence suggests that
asbestos can be weakly genotoxic and/or
act as a tumor promoter. The data are rele-
vant to the respiratory system and to some
but not all cell types. The relevance of
these data for the colon is not clear.
There are no animal or human data
supporting an increased risk ofcolon can-
cer at lower levels of asbestos exposure.
High exposure to asbestos does not pro-
duce colon cancer in animal studies. A
slight increase in risk was observed in
human populations when lung cancer
SMRs were the surrogate measures of
exposure, but there was no exposure
response for colon when quantitative esti-
mates of exposure were available. In these
same studies an exposure-response rela-
tionship was observed for lung cancer.
These results are among the strongest epi-
demiological evidence detracting from the
argument for a causal association. In con-
clusion, asbestos exposure does not appear
to increase the risk ofcolon cancer.
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